Search Results - "Pezzella, V"

Changes over the last two decades in Hemophilia A and B management in a Tertiary Care Pediatric Centre by Esposto, M.P., Bonetti, E., Balter, R., Pezzella, V., Zaccaron, A., Vitale, V., Caddeo, G., Chinello, M., Tridello, G., Poli, G., Cesaro, S.

“…The treatment of Hemophilia A and B has significantly evolved. we conducted a retrospective, observational study among patients with HA and HB managed in a…”
Get full text

UCGI 28 Panirinox: A randomized phase II study assessing Panitumumab + FOLFIRINOX or mFOLFOX6 in RAS and BRAF wild type metastatic colorectal cancer patients (mCRC) selected from circulating DNA analysis by Mazard, T., Ghiringhelli, F., Mollevi, C., Assenat, E., Gavoille, C., Smith, D., Pezzella, V., Meddeb, R., Pastor, B., Ychou, M., Thierry, A.R.

Get full text

Very Late Heart Transplant Rejection Is Associated with Microvascular Injury, Complement Deposition and Progression to Cardiac Allograft Vasculopathy by Loupy, A., Cazes, A., Guillemain, R., Amrein, C., Hedjoudje, A., Tible, M., Pezzella, V., Fabiani, J. N., Suberbielle, C., Nochy, D., Hill, G. S., Empana, J. P., Jouven, X., Bruneval, P., Van Huyen, J. P. Duong

“…In heart transplants, the significance of very late rejection (after 7 years post‐transplant, VLR) detected by routine endomyocardial biopsies (EMB) remains…”
Get full text

Atopy patch tests are useful to predict oral tolerance in children with gastrointestinal symptoms related to non‐IgE‐mediated cow's milk allergy by Nocerino, R., Granata, V., Di Costanzo, M., Pezzella, V., Leone, L., Passariello, A., Terrin, G., Troncone, R., Berni Canani, R.

“…Atopy patch tests (APTs) have been proposed for the diagnostic approach in children with non‐IgE‐mediated cow's milk allergy and gastrointestinal symptoms. We…”
Get full text

Dysbalanced polyunsaturated fatty acids metabolism in cow milk allergy: New clues for pathogenesis understanding and dietary treatment in food allergy by Paparo, L, Nocerino, R, Capasso, M, Agostoni, C, Granata, V, Pezzella, V, Amoroso, A, Montella, M, Canani, R. Berni

Get full text

Hospital admissions for food-induced anaphylaxis in Italian children: A new report for the years 2006–2011 by Nocerino, R, Leone, L, Pezzella, V, Terrin, G, Troncone, R, Berni Canani, R

Get full text

The Activation of mTOR Pathway in Endothelial Cells Correlates with Antibody-Mediated Rejection (AMR) in Endomyocardial Biopsies (EMB) by Tible, M, Loupy, A, Vernerey, D, Beuscart, T, Mandet, C, Guillemain, R, Amrein, C, Suberbielle, C, Cazes, A, Pezzella, V, Charron, D, Jouven, X, Bruneval, P, Duong Van Huyen, J.-P

“…Purpose The pathological classification of AMR in EMB is based on histology (microvascular inflammation) and immunohistochemistry (deposition of C4d and/or…”
Get full text

PO21 THE IMPACT OF A NEW HYPOTONIC SUPER ORS IN GEL FORMULATION ON THE APPLICABILITY OF GUIDELINES FOR MANAGING ACUTE GASTROENTERITIS IN PEDIATRIC CLINICAL PRACTICE by Passariello, A, De Marco, G, Cecere, G, Micillo, M, Pezzella, V, Cosenza, L, Terrin, G, Canani, R. Berni

Get full text

PO24 BENEFIT OF ATOPY PATCH TEST IN DECIDING WHEN TO REINTRODUCE COW'S MILK IN NON-IgE-MEDIATED ALLERGIC CHILDREN WITH GASTROINTESTINAL SYMPTOMS by Nocerino, R, Granata, V, Pezzella, V, Leone, L, Di Costanzo, M, Passariello, A, Terrin, G, Troncone, R, Canani, R. Berni

Get full text

PO32 EFFICACY OF A NEW PARTIALLY HYDROLYZED WHEY FORMULA ON INFANT COLIC: A RANDOMIZED CONTROLLED TRIAL by Nocerino, R, De Marco, G, Cosenza, L, Pezzella, V, Passariello, A, Terrin, G, Canani, R. Berni

Get full text

28 Performance of Routine C4d and C3d Immunostaining on Protocol EMBs in a Prospective and Unselected Cohort of Heart Transplant Patients by Loupy, A, Cazes, A, Guillemain, R, Suberbielle, C, Tible, M, Amrein, C, Pezzella, V, Fabiani, J.-N, Hill, G.S, Nochy, D, Bruneval, P, Duong Van Huyen, J.-P

Get full text

LBA30 Panitumumab (P) + FOLFIRINOX or mFOLFOX6 in unresectable metastatic colorectal cancer (mCRC) patients (pts) with RAS/BRAF wild-type (WT) tumor status from circulating DNA (cirDNA): First results of the randomised phase II PANIRINOX-UCGI28 study by Mazard, T., Ghiringhelli, F., Winter, A., de la Fouchardiere, C., Botsen, D., André, T., Vanbockstael, J., Dos Santos, M., Martin-Babau, J., Rinaldi, Y., Evesque, L., Ellis, S., Gavoille, C., Smith, D., Fonck, M., Sefrioui, D., Pezzella, V., Nougaret, S., Thierry, A.R., Bouche, O.

Get full text

63PEXPRESS study: A multicenter, prospective trial in progress exploring the association between low level of genomic alteration and exceptional and unexpected response to targeted therapies in patients with solid tumors by Le Saux, O, Italiano, A, Spaeth, D, Heudel, P-E, Filleron, T, Pezzella, V, Jimenez, M, Legrand, F, Ferté, C

Get full text

614TiPUCGI 28 Panirinox: A randomized phase II study assessing Panitumumab + FOLFIRINOX or mFOLFOX6 in RAS and BRAF wild type metastatic colorectal cancer patients (mCRC) selected from circulating DNA analysis by Mazard, T, Ghiringhelli, F, Mollevi, C, Assenat, E, Gavoille, C, Smith, D, Pezzella, V, Meddeb, R, Pastor, B, Ychou, M, Thierry, A R

Get full text

837TiPPRODIGE67_UCGI33 ARION: Association of radiochemotherapy and immunotherapy for the treatment of unresectable oesophageal cancer: A comparative randomized phase II trial by Guimbaud, R, Quero, L, Vendrely, V, Tougeron, D, Benerezy, K, Samalin, E, Aparicio, T, Zitvogel, L, Selves, J, Otal, P, Cohen-Jonathan Moyal, E L, Delord, J-P, Pezzella, V, Filleron, T, Modesto, A

“…Abstract Background Overall survival (OS) of locally advanced esophageal cancer remains poor with a 5-year survival of 15-34%. The standard treatment is…”
Get full text

837TiP - PRODIGE67_UCGI33 ARION: Association of radiochemotherapy and immunotherapy for the treatment of unresectable oesophageal cancer: A comparative randomized phase II trial by Guimbaud, R., Quero, L., Vendrely, V., Tougeron, D., Benerezy, K., Samalin, E., Aparicio, T., Zitvogel, L., Selves, J., Otal, P., Cohen-Jonathan Moyal, E.L., Delord, J.-P., Pezzella, V., Filleron, T., Modesto, A.

“…Overall survival (OS) of locally advanced esophageal cancer remains poor with a 5-year survival of 15-34%. The standard treatment is definitive radiotherapy…”
Get full text

PRODIGE67_UCGI33 ARION: Association of radiochemotherapy and immunotherapy for the treatment of unresectable oesophageal cancer: A comparative randomized phase II trial by Guimbaud, R., Quero, L., Vendrely, V., Tougeron, D., Benerezy, K., Samalin, E., Aparicio, T., Zitvogel, L., Selves, J., Otal, P., Cohen-Jonathan Moyal, E.L., Delord, J.-P., Pezzella, V., Filleron, T., Modesto, A.

Get full text

EXPRESS study: A multicenter, prospective trial in progress exploring the association between low level of genomic alteration and exceptional and unexpected response to targeted therapies in patients with solid tumors by Le Saux, O., Italiano, A., Spaeth, D., Heudel, P.-E., Filleron, T., Pezzella, V., Jimenez, M., Legrand, F., Ferté, C.

Get full text

Renal insufficiency, mortality, and drug management in heart transplant. Results of the CARIN study by Janus, Nicolas, Launay-Vacher, Vincent, Sebbag, Laurent, Despins, Philippe, Epailly, Eric, Pavie, Alain, Obadia, Jean-François, Pattier, Sabine, Varnous, Shaïda, Pezzella, Veronica, Trillaud, Laurence, Deray, Gilbert, Guillemain, Romain

“…Renal insufficiency (RI) is a frequent complication in heart transplant (HT) patients. The main objectives of the Cardiac trAnsplantation and Renal…”
Get more information

Atopy patch tests are useful to predict oral tolerance in children with gastrointestinal symptoms related to non‐IgE‐mediated cow's milk allergy by Nocerino, R, Granata, V, Pezzella, V, Leone, L, Di Costanzo, M, Passariello, A, Terrin, G, Troncone, R, Berni Canani, R

Get full text